Low & Intermediate Risk Neuroblastoma

Dr. Holly Meany focuses on the treatment of low and intermediate-risk neuroblastoma (non-high-risk neuroblastoma). Dr. Meany shares how overall the story of non-high-risk neuroblastoma is a successful one, and describes how the success came about, what challenges have been identified and the questions that remain to be answered.
This is a recorded presentation from the 2020 symposium.